Another pharma company is facing supply constraints because of third-party contract manufacturing issues.
On Tuesday, Theratechnologies warned there is a risk its lipodystrophy drug for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.